• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌分离株中的抗生素异质性耐药:系统评价和荟萃分析。

Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis.

机构信息

Department of Pharmacy, Clinical Pharmaceutics Room, Sichuan Science City Hospital, Mianyang, 621000, China.

Sichuan College of Traditional Chinese Medicine, Mianyang, 621000, China.

出版信息

Ann Clin Microbiol Antimicrob. 2021 Oct 13;20(1):73. doi: 10.1186/s12941-021-00478-z.

DOI:10.1186/s12941-021-00478-z
PMID:34645463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8513340/
Abstract

BACKGROUND

Mycobacterium tuberculosis (MTB) is responsible for tuberculosis; that continues to be a public health threat across the globe. Furthermore, increasing heteroresistance (HR)-the presence of resistant and susceptible isolates among MTB strains- has been reported from around the world. This phenomenon can lead to full resistance development and treatment failure.

METHODS

We systematically searched the relevant studies in PubMed, Scopus, and Embase (Until October 21, 2020). The study outcomes revealed the weighted pooled prevalence of antibiotic HR in MTB isolates with subgroup analysis by year, quality of study, and heteroresistance detection method.

RESULTS

A total of 38 studies which had investigated MTB isolates were included in the meta-analysis. Geographically, the highest number of studies were reported from Asia (n  =  24), followed by Africa (n  =  5). Nineteen studies reported HR to isoniazid, with a weighted pooled prevalence of 5% (95% CI 0-12) among 11,761 MTB isolates. Also, there is no important trend for the subgroup analysis by the study period (2001-2014 vs 2015-2017 vs 2018-2020). HR to rifampin was reported in 17 studies, with a weighted pooled prevalence of 7% (95% CI 2-14) among 3782 MTB isolates. HR to fluoroquinolone and ethambutol were reported in 12 and 4 studies, respectively, with weighted pooled prevalence of 10% and 1% among 2153 and 1509 MTB isolates, correspondingly.

CONCLUSION

Based on our analysis, HR in MTB isolates with different frequency rate is present worldwide. Thus, the selection of appropriate and reliable methods for HR detection is crucial for TB eradication.

摘要

背景

结核分枝杆菌(MTB)是导致结核病的原因,在全球范围内仍是一个公共卫生威胁。此外,世界各地都有报道称异质性耐药(HR)——MTB 菌株中存在耐药和敏感分离株的存在——不断增加。这种现象可能导致完全耐药的发展和治疗失败。

方法

我们系统地在 PubMed、Scopus 和 Embase 中搜索了相关研究(截至 2020 年 10 月 21 日)。研究结果显示了 MTB 分离株中抗生素 HR 的加权汇总患病率,并按年份、研究质量和异质性耐药检测方法进行了亚组分析。

结果

共有 38 项研究调查了 MTB 分离株,纳入了荟萃分析。从地理上看,来自亚洲的研究最多(n=24),其次是非洲(n=5)。19 项研究报告了异烟肼的 HR,在 11761 株 MTB 分离株中,加权汇总患病率为 5%(95%CI 0-12)。此外,按研究期间(2001-2014 年、2015-2017 年和 2018-2020 年)进行的亚组分析也没有重要趋势。17 项研究报告了利福平的 HR,在 3782 株 MTB 分离株中,加权汇总患病率为 7%(95%CI 2-14)。12 项和 4 项研究分别报告了氟喹诺酮类和乙胺丁醇的 HR,在 2153 株和 1509 株 MTB 分离株中,加权汇总患病率分别为 10%和 1%。

结论

根据我们的分析,具有不同频率的 MTB 分离株中的 HR 普遍存在于世界各地。因此,选择适当和可靠的 HR 检测方法对于结核病的消除至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d309/8513340/c732dd41e72a/12941_2021_478_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d309/8513340/5e8552e803c6/12941_2021_478_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d309/8513340/c732dd41e72a/12941_2021_478_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d309/8513340/5e8552e803c6/12941_2021_478_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d309/8513340/c732dd41e72a/12941_2021_478_Fig2_HTML.jpg

相似文献

1
Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis.结核分枝杆菌分离株中的抗生素异质性耐药:系统评价和荟萃分析。
Ann Clin Microbiol Antimicrob. 2021 Oct 13;20(1):73. doi: 10.1186/s12941-021-00478-z.
2
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.Xpert MTB/XDR 检测系统用于检测肺结核病及异烟肼、氟喹诺酮类、乙胺丁醇和阿米卡星耐药性。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD014841. doi: 10.1002/14651858.CD014841.pub2.
3
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
4
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
5
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.Xpert MTB/RIF Ultra assay 用于儿童结核病和利福平耐药检测。
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD013359. doi: 10.1002/14651858.CD013359.pub3.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).治疗布鲁里溃疡(溃疡分枝杆菌病)的药物。
Cochrane Database Syst Rev. 2018 Aug 23;8(8):CD012118. doi: 10.1002/14651858.CD012118.pub2.
8
Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis.耐药相关突变在与异烟肼和利福平耐药结核分枝杆菌在埃塞俄比亚的流行情况:一项系统评价和荟萃分析。
J Glob Antimicrob Resist. 2021 Sep;26:207-218. doi: 10.1016/j.jgar.2021.06.009. Epub 2021 Jun 30.
9
Intermittent prophylactic antibiotics for bronchiectasis.支气管扩张症的间歇性预防性抗生素治疗。
Cochrane Database Syst Rev. 2022 Jan 5;1(1):CD013254. doi: 10.1002/14651858.CD013254.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Dissecting rifampicin heteroresistance in : integrating whole-genome sequencing with phenotypic and clonal validation.剖析利福平异质性耐药:将全基因组测序与表型及克隆验证相结合
J Med Microbiol. 2025 Jul;74(7). doi: 10.1099/jmm.0.002048.
2
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.药物敏感和耐药结核病治疗的最新进展:美国胸科学会/美国疾病控制与预防中心/欧洲呼吸学会/美国感染病学会官方临床实践指南
Am J Respir Crit Care Med. 2025 Jan;211(1):15-33. doi: 10.1164/rccm.202410-2096ST.
3
Prevalence of katG and inhA mutations associated with isoniazid resistance in Mycobacterium tuberculosis clinical isolates in Cameroon.

本文引用的文献

1
Prevalence and factors associated with multidrug-resistant tuberculosis in South India.印度南部耐多药结核病的流行情况及相关因素。
Sci Rep. 2020 Oct 16;10(1):17552. doi: 10.1038/s41598-020-74432-y.
2
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs.用于无培养预测对13种抗结核药物敏感性或耐药性的深度扩增子测序
Eur Respir J. 2021 Mar 18;57(3). doi: 10.1183/13993003.02338-2020. Print 2021 Mar.
3
Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
喀麦隆结核分枝杆菌临床分离株中与异烟肼耐药相关的katG和inhA基因突变的流行情况。
BMC Microbiol. 2025 Mar 10;25(1):127. doi: 10.1186/s12866-025-03816-9.
4
The implications of mutations in multiple genes associated with ethambutol resistance among multidrug-resistant tuberculosis isolates from China.中国耐多药结核分枝杆菌分离株中与乙胺丁醇耐药相关的多个基因的突变情况
BMC Microbiol. 2025 Mar 1;25(1):107. doi: 10.1186/s12866-025-03821-y.
5
Investigation of bedaquiline heteroresistance among isolates from Pakistan.巴基斯坦分离株中贝达喹啉异质性耐药情况的调查。
Microbiol Spectr. 2025 Apr;13(4):e0218124. doi: 10.1128/spectrum.02181-24. Epub 2025 Feb 24.
6
Phenotypic drug resistance and genetic mutations linked to resistance among extrapulmonary tuberculosis patients in Ethiopia: Insights from Whole Genome Sequencing.埃塞俄比亚肺外结核患者的表型耐药性及与耐药相关的基因突变:全基因组测序的见解
Res Sq. 2024 Dec 17:rs.3.rs-5302564. doi: 10.21203/rs.3.rs-5302564/v1.
7
Impact of heteroresistance on treatment outcomes of people with drug-resistant TB.异质性耐药对耐多药结核病患者治疗结局的影响。
IJTLD Open. 2024 Oct 1;1(10):466-472. doi: 10.5588/ijtldopen.24.0343. eCollection 2024 Oct.
8
Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study.耐药性肺结核中氟喹诺酮类耐药的风险评估与传播:一项回顾性基因组流行病学研究。
Sci Rep. 2024 Aug 24;14(1):19719. doi: 10.1038/s41598-024-70535-y.
9
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa.耐利福平残留标本的Reflex Xpert MTB/XDR检测:南非一项基于临床实验室的诊断准确性和可行性研究
Open Forum Infect Dis. 2024 Jul 31;11(8):ofae437. doi: 10.1093/ofid/ofae437. eCollection 2024 Aug.
10
Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in Ukraine.基于线探针检测的分子检测对利福平耐药结核病患者个体化治疗的影响:来自乌克兰前瞻性 INNOVA4TB 队列研究的数据。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241249841. doi: 10.1177/17534666241249841.
在埃塞俄比亚亚的斯亚贝巴,对新诊断的肺结核患者分离的结核分枝杆菌进行了多药耐药模式和相关基因突变的分子检测。
PLoS One. 2020 Aug 4;15(8):e0236054. doi: 10.1371/journal.pone.0236054. eCollection 2020.
4
Specific gyrA Gene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance in Mycobacterium tuberculosis Isolates from Beijing, China.特定的gyrA基因突变与中国北京结核分枝杆菌分离株中左氧氟沙星耐药性不一致的高流行率相关。
J Mol Diagn. 2020 Sep;22(9):1199-1204. doi: 10.1016/j.jmoldx.2020.06.010. Epub 2020 Jun 30.
5
Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.同一患者感染耐多药和药敏结核分枝杆菌。
Emerg Infect Dis. 2019 Nov;25(11):2120-2121. doi: 10.3201/eid2511.180638. Epub 2019 Nov 17.
6
How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?常规分子诊断检测结核分枝杆菌利福平异质性耐药的效果如何?
J Clin Microbiol. 2019 Oct 23;57(11). doi: 10.1128/JCM.00717-19. Print 2019 Nov.
7
Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations.结核分枝杆菌氟喹诺酮类药物异质性耐药:通过实验混合人群的基因和表型检测方法的检测。
Sci Rep. 2019 Aug 13;9(1):11760. doi: 10.1038/s41598-019-48289-9.
8
Mechanisms and clinical relevance of bacterial heteroresistance.细菌异质性耐药的机制及临床意义。
Nat Rev Microbiol. 2019 Aug;17(8):479-496. doi: 10.1038/s41579-019-0218-1. Epub 2019 Jun 24.
9
Deciphering Within-Host Microevolution of through Whole-Genome Sequencing: the Phenotypic Impact and Way Forward.通过全基因组测序破译 的宿主内微进化:表型影响与未来方向。
Microbiol Mol Biol Rev. 2019 Mar 27;83(2). doi: 10.1128/MMBR.00062-18. Print 2019 May 15.
10
Validation of the GenoType MTBDR Ver 2.0 assay for detection of rifampicin and isoniazid resistance in complex isolates at UZCHS-CTRC TB research laboratory.在UZCHS-CTRC结核病研究实验室对GenoType MTBDR Ver 2.0检测法检测复杂分离株中利福平及异烟肼耐药性的验证。
Int J Mycobacteriol. 2019 Jan-Mar;8(1):83-88. doi: 10.4103/ijmy.ijmy_170_18.